Clarithromycin delays progression of bronchial epithelial cells from G 1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppression

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 5, 2006, Pages 1738-1744

  Shinkai, Masaharu ^a   Tamaoki, Jun ^c   Kobayashi, Hideo ^b   Kanoh, Soichiro ^b   Motoyoshi, Kazuo ^b   Kute, Tim ^a   Rubin, Bruce K ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; DNA; MACROLIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAF PROTEIN; THREONINE; TYROSINE;

ARTICLE; BRONCHUS MUCOSA; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; FLOW CYTOMETRY; HISTOGRAM; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BRONCHI; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CLARITHROMYCIN; DNA; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; G1 PHASE; HUMANS; MODELS, BIOLOGICAL; S PHASE;

EID: 33646444723     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.5.1738-1744.2006     Document Type: Article

References (31)

1. Abe, S., H. Nakamura, S. Inoue, H. Takeda, H. Saito, S. Kato, N. Mukaida, K. Matsushima, and H. Tomoike. 2000. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 22:51-60.
2. Chen, S. Z., M. Jiang, and Y. S. Zhen. 2005. HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin. Cancer Chemother. Pharmacol. 56:212-220.
3. Compton, M. M., J. S. Haskill, and J. A. Cidlowski. 1988. Analysis of glucocorticoid actions on rat thymocyte deoxyribonucleic acid by fluorescence-activated flow cytometry. Endocrinology 122:2158-2164.
4. Dougherty, M. K., J. Muller, D. A. Ritt, M. Zhou, X. Z. Zhou, T. D. Copeland, T. P. Conrads, T. D. Veenstra, K. P. Lu, and D. K. Morrison. 2005. Regulation of Raf-1 by direct feedback phosphorylation. Mol. Cell 17:215-224.
5. Imamura, Y., K. Yanagihara, Y. Mizuta, M. Seki, H. Ohno, Y. Higashiyama, Y. Miyazaki, K. Tsukamoto, Y. Hirakata, K. Tomono, J. Kadota, and S. Kohno. 2004. Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-oxododecanoyl) homoserine lactone in NC1-H292 cells. Antimicrob. Agents Chemother. 48:3457-3461.
6. Johnson, G. L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK. and p38 protein kinases. Science 298:1911-1912.
7. Kaneko, Y., K. Yanagihara, M. Seki, M. Kuroki, Y. Miyazaki, Y. Hirakata, H. Mukae, K. Tomono, J. Kadota, and S. Kohno. 2003. Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. Am. J. Physiol. Lung Cell. Mol. Physiol. 285:L847-L853.
8. Kim, D. H., H. K. Na, T. Y.Oh, W. B. Kim, and Y. J. Surh. 2004. Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces cell cycle arrest in ras-transformed human mammary epithelial cells. Biochem Pharmacol. 68:1081-1087.
9. Kute, T. E., and Y. Quadri. 1991. Measurement of proliferation nuclear and membrane markers in tumor cells by flow cytometry. J. Histochem. Cytochem. 39:1125-1130.
10. Kute, T. E., Z. M. Shao, N. K. Sugg, R. T. Long, G. B. Russell, and L. D. Case. 1992. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res. 52:5198-5203.
11. Lee, T. K., and I. Stupans. 2002. Radioprotection: the non-steroidal antiinflammatory drugs (NSAIDs) and prostaglandins. J. Pharm. Pharmacol. 54:1435-1445.
12. Mishima, K., K. Inoue, and Y. Hayashi. 2002. Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma. Oral Oncol. 38:468-474.
13. Morris, G. M. 1996. Review article: effects of radiation on the cell proliferation kinetics of epithelial tissues-therapeutic implications. Br. J. Radiol. 69:795-803.
14. Patel, K. B., D. Xuan, P. R. Tessier, J. H. Russomanno, R. Quintiliani, and C. H. Nightingale. 1996. Comparison of bronchopulmonary pharmacokinetics of Clarithromycin and azithromycin. Antimicrob. Agents Chemother. 40:2375-2379.
15. Roovers, K., and R. K. Assoian. 2000. Integrating the MAP kinase signal into the GI phase cell cycle machinery. Bioessays 22:818-826.
16. Rubin, B. K., and J. Tamaoki. 2004. Antibiotics as anti-inflammatory and immunomodulatory agents. Birkhauser Verlag, Basel, Switzerland.
17. Shinkai, M., G. H. Foster, and B. K. Rubin. 2006. Macrolide antibiotics modulate ERK phosphorylation and 1L-8 and GM-CSF production by human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290:L75-L85.
18. Shinkai, M., and B. K. Rubin. 2005. Macrolides and airway inflammation in children. Paediatr. Respir. Rev. 6:227-235.
19. Shinkai, M., N. Shinomiya, S. Kanoh, K. Motoyoshi, and H. Kobayashi. 2004. Oxygen stress effects on proliferation rates and heat shock proteins in lymphocytes. Aviat. Space Environ. Med. 75:109-113.
20. Squires, M. S., P. M. Nixon, and S. J. Cook. 2002. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1. Biochem. J. 366:673-680.
21. Suwa, T., H. Urano, and H. Watanabe. 1988. Pharmacokinetic study of TE-031 (8). Absorption and excretion following oral administration of healthy volunteers. Chemotherapy (Tokyo) 36:75-85. (In Japanese.)
22. Takami, K., N. Takuwa, H. Okazaki, M. Kobayashi, T. Ohtoshi, S. Kawasaki, M. Dohi, K. Yamamoto, T. Nakamura, M. Tanaka, K. Nakahara, Y. Takuwa, and H. Takizawa. 2002. Interferon-gamma inhibits hepatocyte growth factor-stimulated cell proliferation of human bronchial epithelial cells: upregulation of p27(kipl) cyclin-dependent kinase inhibitor. Am. J. Respir. Cell Mol. Biol. 26:231-238.
23. Tamemoto, H., T. Kadowaki, K. Tobe, K. Ueki, T. Izumi, Y. Chatani, M. Kohno, M. Kasuga, Y. Yazaki, and Y. Akanuma. 1992. Biphasic activation of two mitogen-activated protein kinases during the cell cycle in mammalian cells. J. Biol. Chem. 267:20293-20297.
24. Terada, Y., K. Tomita, M. K. Homma, H. Nonoguchi, T. Yang, T. Yamada, Y. Yuasa, E. G. Krebs, S. Sasaki, and F. Marumo. 1994. Sequential activation of Raf-1 kinase, mitogen-activated protein (MAP) kinase kinase, MAP kinase, and S6 kinase by hyperosmolality in renal cells. J. Biol. Chem. 269:31296-31301.
25. Tsai, W. C., M. L. Rodriguez, K. S. Young, J. C. Deng, V. J. Thannickal, K. Tateda, M. B. Hershenson, and T. J. Standiford. 2004. Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. Am. J. Respir. Crit. Care Med. 170:1331-1339.
26. Vicent, S., J. M. Lopez-Picazo, G. Toledo, M. D. Lozano, W. Torre, C. Garcia-Corchon, C. Quero, J. C. Soria, S. Martin-Algarra, R. G. Manzano, and L. M. Montuenga. 2004. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. Br. J. Cancer 90:1047-1052.
27. Vindelov, L. L. 1977. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. Virchows Arch. B 24:227-242.
28. Wagner, D. D., J. B. Olmsted, and V. J. Marder. 1982. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J. Cell Biol. 95:355-360.
29. Webb, C. P., L. Van Aelst, M. H. Wigler, and G. F. Woude. 1998. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc. Natl. Acad. Sci. USA 95:8773-8778.
30. Widmann, C., S. Gibson, M. B. Jarpe, and G. L. Johnson. 1999. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79:143-180.
31. Zhang, W., and H. T. Liu. 2002. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 12:9-18.